GAIX

Pharmaceutical

The pharmaceutical industry leverages AI for drug discovery, clinical trials, manufacturing, and supply chain optimization. Our services help:

Ensure compliance with FDA, EMA, HIPAA, the EU AI Act, CCPA, NIST RMF, ISO 42001, and other regulatory requirements for AI in drug development
Implement validation frameworks for AI models in R&D
Develop governance structures for AI in clinical trials
Ensure data privacy and security in research applications
Manage risks associated with AI in drug discovery and manufacturing

Global Regulatory Expertise

Aligned with HIPAA, FDA, GDPR, the EU AI Act, CCPA, NIST AI RMF, ISO 42001, FCRA, ECOA, GLB, AML Regulations, BSA, USA PATRIOT Act, FinCEN, and other emerging AI laws.

Industry-Specific Solutions

Tailored for finance, healthcare, pharma, manufacturing, supply chains, and government.

Industry-Leading Expertise

Our team brings over three decades of experience in business and AI strategy, governance, risk management, compliance, and AI/ML implementations.

Global AI GRC Leadership

Founded by Dr. Rizwan Amin Sheikh (“Dr. Riz”), an internationally renowned Business & AI Strategist, AI GRC Professional, Author, and Professor with 25+ years of experience in the industry and academia.

Try our Risk-Free Online AI GRC Assessment Model

Schedule a Consultation Start Your AI Risk Assessment

Global AI Excellence (GAIX) is a leader in AI Governance, Risk, and Compliance (GRC), offering innovative software and advisory services to ensure responsible AI adoption. We empower organizations in financial services, healthcare, pharma, manufacturing, supply chain, and the public sector to deploy AI ethically and responsibly while meeting global regulatory requirements.

info@gaix.ai